SCHEMBL6868482

SCHEMBL6868482

CN(C)c1cc(N[C@H]2CC[C@@H](NC(=O)Nc3ccc4c(c3)OCCCO4)CC2)nc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
TP53 P04637 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
HTT P42858 4/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 7/20 0.42
NPSR1 Q6W5P4 4/20 0.42
LMNA P02545 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NPY1R P25929 1/20 0.42
RECQL P46063 1/20 0.42
NPY2R P49146 1/20 0.42
MCHR1 Q99705 1/20 0.41
TRPV1 Q8NER1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6868487 1.00 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6874686 0.97 RAB9A (0.53) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6874693 0.97 RAB9A (0.53) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6873478 0.93 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6873468 0.93 SMN1; SMN2 (0.51) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6874434 0.88 EGFR (0.47) SMN1; SMN2RAB9ANPC1HTTPOLB
SCHEMBL6874447 0.88 EGFR (0.47) SMN1; SMN2RAB9ANPC1HTTPOLB
SCHEMBL4211418 0.85 MCHR1 (0.55) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL4211417 0.85 MCHR1 (0.55) SMN1; SMN2RAB9ANPC1TP53NFKB1
SCHEMBL6874938 0.84 EGFR (0.54) SMN1; SMN2RAB9ANPC1NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed